As AKT activation is crucial for many cancer types, CKB downregulation, as seen in multiple epithelial cancer types, may be an integral part of general mechanisms underlying AKT activation beyond prostate cancer, which warrants further investigation. The gene discussed is AKT1; the disease is prostate carcinoma.